Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Shlomo Bulvik"'
The clinical response of West Nile virus neuroinvasive disease to intravenous immunoglobulin therapy
Publikováno v:
Clinics and Practice, Vol 2, Iss 1 (2012)
The aim of the study was to determine whether intravenous gamma globulin (IVIG) treatment is effective in patients with West Nile Virus (WNV) neuroinvasive disease. We contacted hospital based infectious disease experts in Israeli hospitals to identi
Externí odkaz:
https://doaj.org/article/32737ae009fc497c9849eeaae266198f
Autor:
Leonardo Solmesky, Sharon Lefler, Jasmine Jacob-Hirsch, Shlomo Bulvik, Gideon Rechavi, Miguel Weil
Publikováno v:
PLoS ONE, Vol 5, Iss 9, p e815 (2010)
Human mesenchymal stem cells (hMSC) are easily isolated from the bone marrow by adherence to plastic surfaces. These cells show self-renewal capacity and multipotency. A unique feature of hMSC is their capacity to survive without serum. Under this co
Externí odkaz:
https://doaj.org/article/8b734f45f44047cd8f4a05e6eea46880
Publikováno v:
Emerging Infectious Diseases, Vol 7, Iss 4, Pp 759-759 (2001)
Externí odkaz:
https://doaj.org/article/00f9cb3dbcd848e3994bd72f221205f8
The amyloidoses are a heterogenous group of clinical disorders that share the common finding of the abnormal deposition of insoluble proteins into various organs, with the result that these proteinaceous deposits disrupt cellular function and impair
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5446eeab04fb556b23b51484d713d071
https://doi.org/10.5772/intechopen.97826
https://doi.org/10.5772/intechopen.97826
Publikováno v:
Endocrine Practice. 27:S52-S53
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b4753139f72c64ebba3eb5f65d9da356
https://doi.org/10.1016/j.eprac.2021.04.582
https://doi.org/10.1016/j.eprac.2021.04.582
Autor:
Roman Liberson, Mark Niven, Shlomo Baytner, Michael Frogel, Frank J. Veith, Michael Belkin, Yael Porat, Martin M. Grajower, Shlomo Bulvik, Louis Shenkman, Galit Sivak
Publikováno v:
Stem Cell Therapy for Vascular Diseases ISBN: 9783030569532
Lower extremity arterial disease affects more than 200 × 10e6 people worldwide causing Critical Limb Ischemia (CLI), also referred to as chronic limb-threatening ischemia (CLTI) a life-threatening disease and the major cause of ischemic amputation.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c30c65157436e02f86b2a9564b6ae6a5
https://doi.org/10.1007/978-3-030-56954-9_12
https://doi.org/10.1007/978-3-030-56954-9_12
Autor:
Ron Hoffman, Ilana Hellmann, Tsila Zuckerman, Israel Henig, Revital Saban, Ariella Tvito, Chezi Ganzel, Ariela Arad, Michal Hayun, Jacob M. Rowe, Sharon Gino-Moor, Ronit Leiba, Noa Lavi, Shimrit Ringelstein, Netanel A. Horowitz, Yishai Ofran, Moshe E. Gatt, Avraham Frisch, Ron Ram, Shlomo Bulvik
Publikováno v:
American journal of hematologyREFERENCES. 95(1)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6607a81c51adcbba758ee67c6c4f8ea
https://pubmed.ncbi.nlm.nih.gov/31591736
https://pubmed.ncbi.nlm.nih.gov/31591736
Autor:
Ory Rouvio, Shlomo Bulvik, Tamar Tadmor, Yossi Cohen, Arnon Nagler, Aaron Polliack, Moshe E. Gatt, Yael Cohen, Netanel A Horwitz, Osnat Jarchowsky, Hila Magen, Katrin Herzog, Jacob M. Rowe, Merav Leiba, Chezi Ganzel, Irit Avivi
Publikováno v:
Leukemia research. 68
Primary plasma cell leukemia (PPCL) is a rare form of multiple myeloma with a dismal prognosis. This retrospective multi-center study examines the national experience of PPCL in the era of novel agents. During 2002-2016, thirty-nine patients with PPC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1cd5133b2901e640328a326d6007d16
https://pubmed.ncbi.nlm.nih.gov/29501828
https://pubmed.ncbi.nlm.nih.gov/29501828
Autor:
Ilana Hellmann, Ariela Arad, Yishai Ofran, Netanel A. Horowitz, Tsila Zuckerman, Israel Henig, Michal Hayun, Ronit Leiba, Noa Lavi, Revital Saban, Shimrit Ringelstein, Shlomo Bulvik, Ron Hoffman, Chezi Ganzel, Jacob M. Rowe, Sharon Gino-Moor, Ron Ram, Moshe E. Gatt
Publikováno v:
American Journal of Hematology. 90:1159-1164
Evaluation of early response during induction therapy for acute myeloid leukemia (AML) is used for prognostication and re-induction strategy, yet the optimal evaluation time point is unknown. Clearance of bone marrow (BM) blasts by day 14 of therapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c739043abf062cfb5f6e8f18cf5960e7
https://doi.org/10.1002/ajh.24207
https://doi.org/10.1002/ajh.24207
Autor:
Najib Dally, Sigal Tavor, David Lavie, Anna Courevitch, Maya Koren-Michowitz, Elena Mishchenko, Shlomo Bulvik, Adrian Duek, Odit Gutwein, Noa Lavi, Andrei Braester, Evgeni Chubar, Martin Ellis, Ilya Kirgner
Publikováno v:
Leukemia Research. 39:1154-1158
Ruxolitinib has been shown in two randomized clinical trials to be effective in alleviating systemic symptoms and reducing spleen size in patients with myelofibrosis (MF). We retrospectively evaluated efficacy and tolerability of ruxolitinib in a coh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb7ceb14fe0337cc3e9e325da5b06ceb
https://doi.org/10.1016/j.leukres.2015.08.003
https://doi.org/10.1016/j.leukres.2015.08.003